| |||||||||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Species laboratory mouse Background Strain C57BL/6 Donor Strain 129S2 via D3 ES cell line Generation F6pF1 Donating Investigator Richard Hynes, Massachusetts Institute of Technology Description
Mice homozygous for the Cdh3tm1Hyn targeted mutation (P-cadherin deficient) are viable and fertile with females able to nurse and maintain their litters. Virgin homozygous mutant females display precocious differentiation of the mammary gland. Aging mice develop hyperplasia and dysplasia of the mammary epithelium. In addition, mammary glands from P-cadherin deficient mice show abnormal lymphocyte infiltration.Development
An EcoRI-EcoRI DNA 8.5 kb DNA fragment was isolated from lamda clone, PG21, and subcloned into Bluescript KS. The neo expression cassette, pMC1neo, was digested with XhoI-SalI and subcloned into a unique XhoI site in exon 11. The BamHI-BamHI DNA fragment was subcloned into a plasmid containing the pMC1-HSVTK cassette. The construct was linearized with NotI and electroporated into D3 ES cells, and colonies were selected with G418 and gancyclovir. An EcoRI-BamHI genomic 0.7 kb DNA fragment located immediately 5' to the short arm of the targeting vector was used as a probe. The targeted ES clones were injected into blastocysts from C57BL/6 mice.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Cdh3tm1Hyn/Cdh3tm1Hyn
involves: 129S2/SvPas * C57BL/6
- endocrine/exocrine gland phenotype
- abnormal mammary gland morphology (MGI Ref ID J:44359)
- at 19-24 months of age, virgin female homozygotes exhibit extensive periductal lymphocyte infiltration into the interstitial space of mammary glands
- abnormal mammary gland development (MGI Ref ID J:44359)
- at 10 weeks of age, mammary glands from postpubescent virgin female homoygotes show precocious alveolar differentiation and express casein(s) resembling early (day 14) pregnant wild-type glands
- however, female homozygotes are fertile and able to nurse and maintain a normal size litter, and display normal branching of the mammary ductal tree up to 5 weeks of age
- mammary gland alveolar hyperplasia (MGI Ref ID J:44359)
- at 19-24 months of age, virgin female homozygotes display focal mammary alveolar hyperplasia
- secretory vacuoles are observed in alveoli of aging virgin homozygotes consistent with a differentiated hyperplastic phenotype
- mammary gland duct hyperplasia (MGI Ref ID J:44359)
- at 19-24 months of age, virgin female homozygotes display mammary ductal dysplasia and stromal/fibroblastic hyperplasia with marked lymphocyte infiltration noted around the ducts
- in contrast to the mammary duct epithelium which becomes hyperplastic, the surrounding monolayer of myoepithelial cells remains normal
- mammary gland hyperplasia (MGI Ref ID J:44359)
- at 15 months of age, several multiparous females homozygotes display extensive mammary hyperplasia and dysplasia
- however, no palpable mammary tumors are observed up to 2 years of age
- reproductive system phenotype
- abnormal mammary gland morphology (MGI Ref ID J:44359)
- at 19-24 months of age, virgin female homozygotes exhibit extensive periductal lymphocyte infiltration into the interstitial space of mammary glands
- abnormal mammary gland development (MGI Ref ID J:44359)
- at 10 weeks of age, mammary glands from postpubescent virgin female homoygotes show precocious alveolar differentiation and express casein(s) resembling early (day 14) pregnant wild-type glands
- however, female homozygotes are fertile and able to nurse and maintain a normal size litter, and display normal branching of the mammary ductal tree up to 5 weeks of age
- mammary gland alveolar hyperplasia (MGI Ref ID J:44359)
- at 19-24 months of age, virgin female homozygotes display focal mammary alveolar hyperplasia
- secretory vacuoles are observed in alveoli of aging virgin homozygotes consistent with a differentiated hyperplastic phenotype
- mammary gland duct hyperplasia (MGI Ref ID J:44359)
- at 19-24 months of age, virgin female homozygotes display mammary ductal dysplasia and stromal/fibroblastic hyperplasia with marked lymphocyte infiltration noted around the ducts
- in contrast to the mammary duct epithelium which becomes hyperplastic, the surrounding monolayer of myoepithelial cells remains normal
- mammary gland hyperplasia (MGI Ref ID J:44359)
- at 15 months of age, several multiparous females homozygotes display extensive mammary hyperplasia and dysplasia
- however, no palpable mammary tumors are observed up to 2 years of age
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Cdh3tm1Hyn related
Cancer Research
Defects in Cell Adhesion Molecules
Increased Tumor Incidence
Mammary Gland Tumors
| Allele Symbol | Cdh3tm1Hyn | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Richard O Hynes | ||
| Allele Type | Targeted (knock-out) | ||
| Mutation Made By | Richard Hynes, Massachusetts Institute of Technology | ||
| Strain of Origin | 129S2/SvPas | ||
| ES Cell Line Name | D3 | ||
| ES Cell Line Strain | 129S2/SvPas | ||
| Gene Symbol and Name | Cdh3, cadherin 3 | ||
| Chromosome | 8 | ||
| Gene Common Name(s) | AI385538; CDHP; Cadp; HJMD; P-cadherin; PCAD; Pcad; expressed sequence AI385538; placental cadherin; | ||
| Molecular Note | A neomycin phosphotransferase expression cassette was inserted into a unique XhoI site in exon 11. Western analysis of placental lysates from intercross progeny did not detect expression of the protein in homozygous mice. [MGI Ref ID J:44539] | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Genotyping resources and troubleshooting
Radice GL; Ferreira-Cornwell MC; Robinson SD; Rayburn H; Chodosh LA; Takeichi M; Hynes RO. 1997. Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 139(4):1025-32. [PubMed: 9362520] [MGI Ref ID J:44359]
Cdh3tm1Hyn relatedLenormand T; Fel-Clair F; Manolakou K; Alibert P; Britton-Davidian J. 1997. Chromosomal transmission bias in laboratory hybrids between wild strains of the two European subspecies of house mice. Genetics 147(3):1279-87. [PubMed: 9383070] [MGI Ref ID J:44539]
Lenox JM; Koch PJ; Mahoney MG; Lieberman M; Stanley JR; Radice GL. 2000. Postnatal lethality of P-cadherin/desmoglein 3 double knockout mice: demonstration of a cooperative effect of these cell adhesion molecules in tissue homeostasis of stratified squamous epithelia. J Invest Dermatol 114(5):948-52. [PubMed: 10771476] [MGI Ref ID J:62092]
Rhee H; Polak L; Fuchs E. 2006. Lhx2 maintains stem cell character in hair follicles. Science 312(5782):1946-9. [PubMed: 16809539] [MGI Ref ID J:110119]
Tinkle CL; Pasolli HA; Stokes N; Fuchs E. 2008. New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrity. Proc Natl Acad Sci U S A 105(40):15405-10. [PubMed: 18809908] [MGI Ref ID J:144091]
Colony Maintenance
Breeding & Husbandry This stain is on a C57BL/6 background and the current backcross generation is N5. The strain is maintained by homozygous matings. Homozygotes are viable and fertile.The donating lab maintained these mice by avoiding brother-sister matings. Expected coat color from breeding:Black Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.